Pneumonia in Nursing Homes and Long-Term Care Facilities

ABSTRACT

This article reviews the epidemiology of pneumonia in residents of nursing homes and other long-term care facilities (LTCFs). Streptococcus pneumoniae is the most important cause of pneumonia in residents of nursing homes and LTCFs. Factors suggestive of aspiration are the most important risk factors for pneumonia in this population. The clinical presentation of pneumonia among long-term care facility residents is challenging; residents tend to be older and more debilitated than their elderly community-dwelling counterparts. Data on optimal antimicrobial therapy in this setting is sparse. Functional status is an important predictor of outcome in this population. There are key management issues, such as site of care, which remain unresolved. Immunization with influenza and pneumococcal vaccines remains the mainstay of prevention.

KEYWORDS

Pneumonia - aging - respiratory - long-term care facilities - nursing homes

REFERENCES

• 1 Muder R. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention.  Am J Med. 1998;  105 319-330
• 2 Spillman B C, Lubitz J. The effect of longevity on spending for acute and long-term care.  N Engl J Med. 2000;  342 1409-1415
• 3 Valenti W M, Trudell R G, Bentley D W. Factors predisposing to oropharyngeal colonization with gram-negative bacilli in the aged.  N Engl J Med. 1978;  298 1108-1111
• 4 Jokinen C, Heiskanen L, Juvonen H et al.. Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland.  Clin Infect Dis. 2001;  32 1141-1154
• 5 Kupronis B A, Richards C L, Whitney C G. Invasive pneumococcal disease in older adults residing in long-term care facilities and in the community.  J Am Geriatr Soc. 2003;  51 1520-1525
• 6 Nuorti J P, Butler J C, Crutcher J M et al.. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents.  N Engl J Med. 1998;  338 1861-1868
• 7 Ruiz M, Ewig S, Marcos M et al.. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.  Am J Respir Crit Care Med. 1999;  160 397-405
• 8 Terpenning M S, Taylor G W, Lopatin D, Kerr C, Dominguez B L, Loesche W J. Aspiration pneumonia: dental and oral risk factors in an older veteran population.  J Am Geriatr Soc. 2001;  49 557-563
• 9 Loeb M, Simor A E, Krueger P et al.. Two nursing home outbreaks of respiratory infection with Legionella sainthelensi .  J Am Geriatr Soc. 1999;  47 547-552
• 10 Maesaki S, Kohno S, Kog H et al.. An outbreak of legionnaires' pneumonia in a nursing home.  Intern Med. 1992;  31 508-512
• 11 Troy C J, Peeling R W, Ellis A G et al.. Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes.  JAMA. 1997;  277 1214-1218
• 12 Orr P H, Peeling R W, Fast M et al.. Serological study of responses to selected pathogens causing respiratory tract infection in the institutionalized elderly.  Clin Infect Dis. 1996;  23 1240-1245
• 13 Seenivasan M, Yu V, Muder R. Legionnaires' disease in long-term care facilities: overview and proposed solutions.  J Am Geriatr Soc. 2005;  53 875-880
• 14 Mills G D, Oehley M, Arrol B. Effectiveness of beta-lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis.  BMJ. 2005;  330 456
• 15 Loeb M, McGeer A, McArthur M et al.. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities.  Arch Intern Med. 1999;  159 2058-2064
• 16 Quagliarello V, Ginter S, Han L, Van Ness P, Allore H, Tinetti M. Modifiable risk factors for nursing home-acquired pneumonia.  Clin Infect Dis. 2005;  40 1-6
• 17 Vergis E N, Brennen C, Wagener M et al.. Pneumonia in long-term care: a prospective case-control study of risk factors and impact on survival.  Arch Intern Med. 2001;  161 2378-2381
• 18 Koivula I, Sten M, Makela P H. Risk factors for pneumonia in the elderly.  Am J Med. 1994;  96 313-320
• 19 Meehan T P, Chua-Reyes J M, Tate J et al.. Process of care performance, patient characteristics, and outcomes in elderly patients hospitalized with community-acquired or nursing home-acquired pneumonia.  Chest. 2000;  117 1378-1385
• 20 Marrie T J, Blanchard W. A comparison of nursing home-acquired pneumonia patients with patients with community-acquired pneumonia and nursing home patients without pneumonia.  J Am Geriatr Soc. 1997;  45 50-55
• 21 Lim W S, Macfarlane J T. A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia.  Eur Respir J. 2001;  18 362-368
• 22 Mylotte J M, Goodnough S, Naughton B J. Pneumonia versus aspiration pneumonitis in nursing home residents: diagnosis and management.  J Am Geriatr Soc. 2003;  51 17-23
• 23 Phillips S L, Branaman-Phillips J. The use of intramuscular cefoperazone versus intramuscular ceftriaxone in patients with nursing home-acquired pneumonia.  J Am Geriatr Soc. 1993;  41 1071-1074
• 24 Hirata-Dulas C A, Stein D J, Guay D R, Gruninger R P, Peterson P K. A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections.  J Am Geriatr Soc. 1991;  39 979-985
• 25 Peterson P K, Stein D, Guay D RP et al.. Prospective study of lower respiratory tract infections in an extended-care nursing home program: potential role of oral ciprofloxacin.  Am J Med. 1988;  85 164-171
• 26 Naughton B J, Mylotte J M. Antibiotic use, hospital admissions, and mortality before and after implementing guidelines for nursing home-acquired pneumonia.  J Am Geriatr Soc. 2001;  49 1020-1024
• 27 Muder R R, Brennen C, Swenson D L, Wagener M. Pneumonia in a long-term care facility: a prospective study of outcome.  Arch Intern Med. 1996;  156 2365-2370
• 28 Mehr D R, Binder E F, Kruse R L et al.. Predicting mortality in nursing home residents with lower respiratory tract infection: The Missouri LRI Study.  JAMA. 2001;  286 2427-2436
• 29 Mylotte J M, Naughton B, Saludades C, Maszarovics Z. Validation and application of the pneumonia prognosis index to nursing home residents with pneumonia.  J Am Geriatr Soc. 1998;  46 1538-1544
• 30 Bula C J, Ghilardi G, Wietlisbach V, Petignat C, Francioli P. Infections and functional impairment in nursing home residents: a reciprocal relationship.  J Am Geriatr Soc. 2004;  2 700-706
• 31 Degelau J, Guay D, Straub K, Luxenberg M G. Effectiveness of oral antibiotic treatment in nursing home-acquired pneumonia.  J Am Geriatr Soc. 1995;  43 245-251
• 32 Thompson R S, Hall N K, Szpiech M, Reisenberg L A. Treatments and outcomes of nursing-home acquired pneumonia.  J Am Board Fam Pract. 1997;  10 82-87
• 33 Fried T R, Gillick M R, Lipsitz L A. Whether to transfer? Factors associated with hospitalization and outcome of elderly long-term care patients with pneumonia.  J Gen Intern Med. 1995;  10 246-250
• 34 Fried T R, Gillick M R, Lipsitz L A. Short-term functional outcomes of long-term care residents with pneumonia treated with and without hospital transfer.  J Am Geriatr Soc. 1997;  45 302-306
• 35 Kruse R L, Mehr D R, Boles K E et al.. Does hospitalization impact survival after lower respiratory infection in nursing home residents?.  Med Care. 2004;  42 860-870
• 36 Konetzka R T, Spector W, Shaffer T. Effects of nursing home ownership type and resident payer source on hospitalization for suspected pneumonia.  Med Care. 2004;  42 1001-1008
• 37 Gross P A, Hermogenes A W, Sacks H S, Lau J, Levandowski R A. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature.  Ann Intern Med. 1995;  123 518-527
• 38 Simonsen L, Reichert T A, Viboud C, Blackwelder W C, Taylor R J, Miller M A. Impact of influenza vaccination on seasonal mortality in the US elderly population.  Arch Intern Med. 2005;  165 265-272
• 39 Nichol K L, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.  Arch Intern Med. 1998;  158 1769-1776
• 40 Nordin J, Mullooly J, Poblete S et al.. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York and Oregon: data from 3 health plans.  J Infect Dis. 2001;  184 665-670
• 41 Nichol K L, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly.  N Engl J Med. 2003;  348 1322-1332
• 42 Potter J, Stott D J, Roberts M A et al.. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients.  J Infect Dis. 1997;  175 1-6
• 43 Carman W F, Elder A G, Wallace L A et al.. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial.  Lancet. 2000;  355 93-97
• 44 Fine M, Smith M A, Carson C A et al.. Efficacy of pneumococcal vaccination in adults: a meta-analysis of randomized controlled trials.  Arch Intern Med. 1994;  154 2666-2677
• 45 Hutchison B G, Oxman A D, Shannon H S, Lloyd S, Altmayer C A, Thomas K. Clinical effectiveness of pneumococcal vaccine.  Can Fam Physician. 1999;  45 2381-2393
• 46 Moore R A, Wiffen P J, Lipsky B A. Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials.  BMC Family Practise. 2000;  1 1
• 47 Cornu C. Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials.  Vaccine. 2001;  19 4780-4790
• 48 Bardenheier B, Shefer A, McKibben L, Roberts H, Bratzler D. Characteristics of long-term-care facility residents associated with receipt of influenza and pneumococcal vaccinations.  Infect Control Hosp Epidemiol. 2004;  25 946-954
• 49 Dehart M P, Salinas S K, Barnette Jr L J et al.. Project Protect: pneumococcal vaccination in Washington State nursing homes.  J Am Med Dir Assoc. 2005;  6 91-96